Pro Vise Management Group, LLC Gsk PLC Transaction History

Pro Vise Management Group, LLC

$1.25 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$42.05 - $47.77 $337,703 - $383,640	-8,031 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$40.23 - $47.74 $94,902 - $112,618	-2,359 Reduced 22.7%	8,031 $350,000
Q4 2021 Jan 18, 2022	SELL	$38.88 - $45.31 $95,256 - $111,009	-2,450 Reduced 19.08%	10,390 $458,000
Q3 2021 Oct 20, 2021	BUY	$38.79 - $43.16 $116,370 - $129,479	3,000 Added 30.49%	12,840 $491,000
Q4 2020 Jan 19, 2021	BUY	$34.07 - $39.94 $579 - $678	17 Added 0.17%	9,840 $362,000
Q2 2020 Aug 07, 2020	SELL	$37.87 - $43.58 $18,935 - $21,790	-500 Reduced 4.84%	9,823 $401,000
Q1 2020 May 07, 2020	SELL	$32.47 - $48.83 $8,539 - $12,842	-263 Reduced 2.48%	10,323 $391,000
Q4 2019 Feb 11, 2020	SELL	$42.0 - $48.25 $16,800 - $19,300	-400 Reduced 3.64%	10,586 $497,000
Q3 2019 Nov 13, 2019	SELL	$40.46 - $43.52 $32,853 - $35,338	-812 Reduced 6.88%	10,986 $469,000
Q2 2019 Aug 09, 2019	SELL	$39.4 - $42.7 $3,940 - $4,270	-100 Reduced 0.84%	11,798 $472,000
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $93,995 - $104,035	-2,437 Reduced 17.0%	11,898 $497,000
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $41,277 - $46,617	-1,092 Reduced 7.08%	14,335 $548,000
Q3 2018 Nov 05, 2018	BUY	$39.75 - $42.69 $3,975 - $4,269	100 Added 0.65%	15,427 $620,000
Q2 2018 Aug 13, 2018	SELL	$39.61 - $42.76 $11,883 - $12,828	-300 Reduced 1.92%	15,327 $618,000
Q1 2018 May 09, 2018	BUY	$36.18 - $40.15 $57,888 - $64,240	1,600 Added 11.41%	15,627 $610,000
Q4 2017 Feb 07, 2018	SELL	$35.34 - $41.9 $544,165 - $645,176	-15,398 Reduced 52.33%	14,027 $497,000
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $1.16 Million - $1.22 Million	29,425	29,425 $1.19 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.

Account